316 related articles for article (PubMed ID: 33713043)
1. The double-edged sword of Tregs in M tuberculosis, M avium, and M absessus infection.
Verma D; Chan ED; Ordway DJ
Immunol Rev; 2021 May; 301(1):48-61. PubMed ID: 33713043
[TBL] [Abstract][Full Text] [Related]
2. Sudapyridine (WX-081) antibacterial activity against
Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
[TBL] [Abstract][Full Text] [Related]
3. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
[TBL] [Abstract][Full Text] [Related]
4. Genome-Wide Essentiality Analysis of
Rifat D; Chen L; Kreiswirth BN; Nuermberger EL
mBio; 2021 Jun; 12(3):e0104921. PubMed ID: 34126767
[TBL] [Abstract][Full Text] [Related]
5. Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan.
Karamat A; Ambreen A; Ishtiaq A; Tahseen S; Rahman MA; Mustafa T
BMC Infect Dis; 2021 Apr; 21(1):381. PubMed ID: 33894767
[TBL] [Abstract][Full Text] [Related]
6. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
[TBL] [Abstract][Full Text] [Related]
7. General Overview of Nontuberculous Mycobacteria Opportunistic Pathogens:
To K; Cao R; Yegiazaryan A; Owens J; Venketaraman V
J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32781595
[TBL] [Abstract][Full Text] [Related]
8. Nontuberculous Mycobacterial Lung Diseases Caused by Mixed Infection with Mycobacterium avium Complex and Mycobacterium abscessus Complex.
Shin SH; Jhun BW; Kim SY; Choe J; Jeon K; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104265
[No Abstract] [Full Text] [Related]
9. Differential Responses by Human Macrophages to Infection With
Feng Z; Bai X; Wang T; Garcia C; Bai A; Li L; Honda JR; Nie X; Chan ED
Front Microbiol; 2020; 11():116. PubMed ID: 32117140
[No Abstract] [Full Text] [Related]
10. Assessment of current diagnostic algorithm for detection of mixed infection with Mycobacterium tuberculosis and nontuberculous mycobacteria.
Liang Q; Shang Y; Huo F; Xue Y; Li Y; Dong L; Li S; Pang Y
J Infect Public Health; 2020 Dec; 13(12):1967-1971. PubMed ID: 32335022
[TBL] [Abstract][Full Text] [Related]
11. Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin.
Blanchard JD; Elias V; Cipolla D; Gonda I; Bermudez LE
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012773
[TBL] [Abstract][Full Text] [Related]
12. Aerosolization of Mycobacterium avium and Mycobacterium abscessus from a household ultrasonic humidifier.
Hamilton LA; Falkinham JO
J Med Microbiol; 2018 Oct; 67(10):1491-1495. PubMed ID: 30113303
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticulate β-Cyclodextrin with Gallium Tetraphenylporphyrin Demonstrates in Vitro and in Vivo Antimicrobial Efficacy against
Choi SR; Talmon GA; Britigan BE; Narayanasamy P
ACS Infect Dis; 2021 Aug; 7(8):2299-2309. PubMed ID: 34314150
[TBL] [Abstract][Full Text] [Related]
14. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
[TBL] [Abstract][Full Text] [Related]
15. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
[TBL] [Abstract][Full Text] [Related]
16. PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population.
Zhang Q; Xiao H; Yan L
BMC Infect Dis; 2021 Mar; 21(1):264. PubMed ID: 33726688
[TBL] [Abstract][Full Text] [Related]
17. Exposure to Mycobacterium avium can modulate established immunity against Mycobacterium tuberculosis infection generated by Mycobacterium bovis BCG vaccination.
Flaherty DK; Vesosky B; Beamer GL; Stromberg P; Turner J
J Leukoc Biol; 2006 Dec; 80(6):1262-71. PubMed ID: 16968819
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the LiPA MYCOBACTERIA assay for identification of mycobacterial species from BACTEC 12B bottles.
Miller N; Infante S; Cleary T
J Clin Microbiol; 2000 May; 38(5):1915-9. PubMed ID: 10790121
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 or tumor necrosis factor-alpha augmented the cytotoxic effect of mycobacteria on human fibroblasts: application to evaluation of pathogenesis of clinical isolates of Mycobacterium tuberculosis and M. avium complex.
Takii T; Abe C; Tamura A; Ramayah S; Belisle JT; Brennan PJ; Onozaki K
J Interferon Cytokine Res; 2001 Mar; 21(3):187-96. PubMed ID: 11331042
[TBL] [Abstract][Full Text] [Related]
20. A Pivotal Role for Mycobactin/
Foreman M; Kolodkin-Gal I; Barkan D
Microbiol Spectr; 2022 Dec; 10(6):e0262322. PubMed ID: 36321891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
